Leila Nicolas Overview
- Firm
- GO Capital (Fran...
- Primary Position
-
Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
7
- Med. Deal Size
-
- Med. Valuation
-
Leila Nicolas General Information
Biography
Ms. Leila Nicolas serves as Partner at GO Capital. She serves as Board Member at TRiCares. She serves as a Board Member of I-Sep, Horama, Acticor Biotech, Atlanthera, and VitaDX. She served as Board Member at Carlina Technologies. She also served as Board Member at SurfactGreen. She graduated with a master's degree in Cellular Biology and Neurosciences from the University of Bordeaux II, she completed her training with a Master's in Health Business Management (IAE Lille) and a certificate in Finance (ICN Nancy).
Contact Information
Address
- 1A rue Louis Braille Courrouze
- Saint Jacques de la Lande
- 35136 Rennes
- France
Leila Nicolas Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| GO Capital (France) | Investor | Partner | Rennes, France | Venture Capital |
Leila Nicolas Board Seats (7)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| Acticor Biotech | Biotechnology | Publicly Held | Formerly VC-backed | Paris, France | |
| Atlanthera | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Nantes, France | |
| Coave Therapeutics | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
| i-SEP | Surgical Devices | Privately Held (backing) | Venture Capital-Backed | Nantes, France | |
| Pherecydes Pharma | Drug Discovery | Acquired/Merged (Operating Subsidiary) | Formerly VC-backed | Nantes, France |
Leila Nicolas Lead Partner on Deals (18)
Leila Nicolas has been the lead partner on 18 deals. Their latest deal was with TRiCares, a surgical devices company. The deal was made for on 15-Sep-2022.
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| TRiCares | 15-Sep-2022 | Later Stage VC (Series C) | Completed | Surgical Devices | Aschheim, Germany | |
| Coave Therapeutics | 02-Dec-2021 | Completed | Drug Discovery | Paris, France | ||
| VitaDX | 04-Sep-2020 | Completed | Diagnostic Equipment | Rennes, France | ||
| Acticor Biotech | 06-Nov-2019 | Completed | Biotechnology | Paris, France | ||
| i-SEP | 14-Oct-2019 | Completed | Surgical Devices | Nantes, France | ||
| VitaDX | 15-Jul-2019 | Completed | Diagnostic Equipment | Rennes, France | ||
| SurfactGreen | 27-Sep-2018 | Completed | Multi-line Chemicals | Rennes, France | ||
| Coave Therapeutics | 18-Sep-2018 | Completed | Drug Discovery | Paris, France | ||
| TRiCares | 04-Jun-2018 | Later Stage VC (Series B) | Completed | Surgical Devices | Aschheim, Germany | |
| Pherecydes Pharma | 16-Jan-2018 | Later Stage VC (Series B) | Completed | Drug Discovery | Nantes, France |
Leila Nicolas Network (140)
Board Members (62)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Christine Placet | Coave Therapeutics | Self | Paris, France | |
| Timur Avdeenko Ph.D | Acticor Biotech | Primer Capital | Paris, France | |
| Pherecydes Pharma | Self | Nantes, France | ||
| Acticor Biotech | Self | Paris, France | ||
| Kemiwatt | GO Capital (France) | Rennes, France |
Portfolio Executives (64)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Coralie Marchand | TRiCares | Co-Founder | 15-Sep-2022 | Aschheim, Germany |
| Lubos Cechvala | TRiCares | Financial Director | 15-Sep-2022 | Aschheim, Germany |
| TRiCares | Co-Founder & Chief Executive Officer | 15-Sep-2022 | Aschheim, Germany | |
| TRiCares | President, Managing Director & Chief Executive Officer | 15-Sep-2022 | Aschheim, Germany | |
| TRiCares | Chief Operating Officer | 15-Sep-2022 | Aschheim, Germany |
Fund Team Members (14)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Guillaume Loudenot | GO Capital (France) | Go Capital Amorçage III | Rennes, France |
| Aude Kermarrec | GO Capital (France) | Ouest Ventures III | Rennes, France |
| GO Capital (France) | Rennes, France | ||
| GO Capital (France) | Rennes, France | ||
| GO Capital (France) | Rennes, France |
Leila Nicolas Affiliated Funds (4)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| GO Capital Amorçage | GO Capital (France) | Venture Capital - Early Stage | Closed | 2012 | ||||
| Go Capital Amorçage III | GO Capital (France) | Venture Capital - Early Stage | Open | 2023 | ||||
| Go Capital Amorçage II | GO Capital (France) | Venture Capital - Early Stage | Closed | 2017 | ||||
| Ouest Ventures III | GO Capital (France) | Venture - General | Closed | 2015 |
Leila Nicolas FAQs
-
Who is Leila Nicolas?
Ms. Leila Nicolas serves as Partner at GO Capital.
-
How much does Leila Nicolas typically invest?
Leila Nicolas's median deal size is .
-
What is Leila Nicolas’s main position?
Leila Nicolas’s primary position is Partner.
-
What are the contact details for Leila Nicolas?
Leila Nicolas’s email address is le and his phone number is +33 02 .
-
How many active board seats does Leila Nicolas hold?
Leila Nicolas holds 7 board seats including Acticor Biotech, Atlanthera, Coave Therapeutics, i-SEP, and Pherecydes Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
